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Abstract: Prenatal monitoring of Fetal Heart Rate (FHR) is crucial for the prevention of fetal
pathologies and unfavorable deliveries. However, the most commonly used Cardiotocographic exam
can be performed only in hospital-like structures and requires the supervision of expert personnel. For
this reason, a wearable system able to continuously monitor FHR would be a noticeable step towards
a personalized and remote pregnancy care. Thanks to textile electrodes, miniaturized electronics, and
smart devices like smartphones and tablets, we developed a wearable integrated system for everyday
fetal monitoring during the last weeks of pregnancy. Pregnant women at home can use it without
the need for any external support by clinicians. The transmission of FHR to a specialized medical
center allows its remote analysis, exploiting advanced algorithms running on high-performance
hardware able to obtain the best classification of the fetal condition. The system has been tested on a
limited set of pregnant women whose fetal electrocardiogram recordings were acquired and classified,
yielding an overall score for both accuracy and sensitivity over 90%. This novel approach can open a
new perspective on the continuous monitoring of fetus development by enhancing the performance
of regular examinations, making treatments really personalized, and reducing hospitalization or
ambulatory visits.
Keywords: tele-monitoring; wearable devices; fetal heart rate; telemedicine
1. Introduction
In the last two decades, research has been very active in developing wearable devices and
systems for medical-oriented applications, often aimed at continuously monitoring patients in their
environment and during daily life activities. The need is a sustainable health system that can
manage acute care (in hospital or emergency departments), and care of outpatients (mainly chronic),
including healthy citizens during their normal life, in order to prevent possible diseases by means of
tele-monitoring [1].
Until the most recent developments in Information and Communication Technologies (ICT), some
limitations in connections and transmission rates allowed only collecting and sending few parameters
in real-time, but nowadays it is possible to realize continuous surveillance of physiological signals.
Thanks to the introduction of new miniaturized sensors and devices, together with the improvements
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in wireless transmission, the remote management of chronic diseases has become a reality, and studies
prove that patients are willing to adopt it [2].
Nowadays, the switch to domiciliary care for non-critical medical issues is seen in many health care
areas as a way to achieve better control over chronic diseases and consequently delay the occurrence
of any complications, avoid unneeded hospitalizations, and reduce pressure over national budgets [3].
Many exploitations of structured tele-monitoring systems have already been carried out in patients
with heart failure [4,5]. The CarelinkTM Network, for example, has been introduced by Medtronic to
improve the management of patients suffering from heart failure that undergo treatments based on
Implantable Cardioverter Devices (ICD) [6]. The literature shows that whenever ICDs are coupled with
a remote monitoring service, not only it is possible to earlier detect any problem concerning the devices
themselves, but also the therapy may be better optimized and individualized for each patient [7]. Even
research projects investigating new treatments that pose significant threats to outpatients’ health are
increasingly relying on a real-time telemonitoring of clinical parameters for immediate processing and
early detection of abnormal or hazardous conditions [8].
Furthermore, the great comfort of subjects in wearing miniaturized sensors, along with an
increasing general health care policy of prevention, have promoted remote monitoring applications
also in the healthy population. Recently, wearable systems have been adopted to monitor healthy
subjects acting in extreme environments [9], performing highly risky activities such as firefighting [10],
doing physical training [11], or wellness exercises [12]. A boost in this direction is given by the
appearance of new textile materials that allow embedding low-cost wearable sensors and computing
devices in standard duty outfits. Sensorized garments combined with tele-monitoring services may
therefore be applied also to healthy people for detecting signals in subjects while they are engaged
in their daily activities with the aim of preventing or anticipating the occurrence of unusual or
pathological conditions.
Pregnancy and fetal states may also effectively resort to tele-monitoring. Although pregnancy in
itself is not a pathology, the fetal condition should be monitored as often as possible in order to prevent
unfavorable outcomes. The literature shows that pregnant women could highly benefit by a remote
monitoring service that is particularly effective for those patients and also helps in achieving a more
efficient use of the health care [13,14]. This is because the reduction of in- or out-stays for patients only
undergoing routine examinations mitigates the shortages of beds in hospitals and reduces any related
management costs. Therefore, it is desirable to design and implement wearable systems that allow
the effective monitoring of pregnant women in different life conditions and evaluate both possible
acute effects (emergency, risky conditions for the fetus), or non-acute effects related to unhealthy
lifestyles. These factors, though not immediately life-threatening, may be the cause of pathologies in
the long term.
The potential market for these systems is enormous. The number of deliveries in Italy is nearly
500.000 every year and the public healthcare system foresees a minimum of 3 monitoring sessions for
each pregnancy. However, a single exam in the last quarter is often not enough to completely assess
the situation and take appropriate decisions. So the number of monitoring sessions in Italy can be
higher than 1.5 M per year.
The most common exam for evaluating the fetal wellbeing is Cardiotocographic (CTG) monitoring,
which consists of measuring Fetal Heart Rate (FHR) and mother uterine contractions. In fact, fetal
wellness is very strongly related with heart functioning, which makes measuring the FHR so important.
CTG technology is based on a doppler ultrasound probe placed on the maternal abdomen and can
only be accomplished in hospital-like structures, since it requires the supervision of expert personnel.
Recognition of the echoes generated by the opening and closing of the cardiac valves of the fetus
allows for the measuring of the position of the beats in time and therefore the computing of the FHR.
In the last twenty years, advances in CTG analysis have improved the quality of FHR feature
extraction in order to obtain reliable indications of disease development. Great contributions arrived
from advanced processing methods that provided novel parameters that were able to discriminate
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fetal states and healthy vs. disease groups [15,16]. These encouraging results pushed even more the
research efforts to explore novel solutions towards FHR monitoring. Even if CTG is the most used
technology, it still remains an indirect way to measure the fetal heartbeat. More importantly, it does
not allow continuous FHR recordings, since data can only be collected at some certain fixed times,
possibly separated by tenths of days if not by months.
For this reason, we started the Telefetalcare project [17], which aims to design and realize a
wearable fetal tele-monitoring system that is able to collect FHR throughout the last period of the
pregnancy. Its key point is the integration of a specific technology (i.e., wearable sensors and electronics)
with consumer ICT devices (i.e., smartphones and tablets) and remote, high-level signal processing,
data mining, and clinical decision support systems. Available methods of machine learning and
artificial intelligence, applied to FHR, can be employed to improve diagnosis and prediction in
pregnancy healthcare processes [18]. Furthermore, the large amount of available data already classified
in CTG analysis, both in normal and pathological fetuses, ensures a robust (solid) clinical reference
for the development of a new monitoring system [19]. In fact, rich clinical classified and annotated
databases can be used as a knowledge source to generate reliable decision support systems. These
approaches can open a new perspective on the continuous monitoring of fetal development: further
information can be extracted by introducing novel analysis tools, which are more sensitive to fetal
states both in healthy and stress conditions, by increasing the length, frequency, and quality of
monitoring session.
Telefetalcare provides the opportunity to enlarge the time window of fetal and maternal
data collection. It can enhance the performances of regular examinations, make treatments really
personalized, and reduce the effort needed when a constant supervision is required.
2. Materials and Methods
2.1. Overview of the System
The system we are presenting here is the evolution of Telefetalcare [17], a project started in
2010 and aimed at developing a new pregnancy-wearable monitoring system, suited for domiciliary
use. Although many different techniques are currently used to monitor FHR in the clinical
practice (CTG, abdominal ECG, fetal scalp ECG, MECG, etc.), the primary need of realizing a
wearable non-invasive and low-cost device encouraged the choice of measuring the abdominal
Electrocardiogram (ECG).
Two major difficulties arise when using this technique: first, the separation of the maternal and
the Fetal ECG (FECG) is compulsory, because they are both revealed through electrodes; second,
the presence of the “vernix caseosa” during the 29th–31st weeks of the pregnancy makes it almost
impossible to measure the FECG. The first problem has been solved through the use of multiple ECG
leads and intelligent signal processing, as reported in the following, while the second still remains and
limits the use of the system to the last weeks of pregnancy (32–42).
Moreover, when it comes to acquiring ECG signals, one of the problems faced by patients, as
they start monitoring themselves, originates from their inability to properly position the electrodes.
This happens because standard Ag/AgCl electrodes need to be correctly positioned and attached
one-by-one using gel and glue, which is a challenging task for inexperienced users, such as pregnant
women at home. For these reasons, we decided to design a wearable bodysuit provided with ECG
textile electrodes specifically placed to measure abdominal FECG.
The Telefetalcare system encompasses a wearable unit, a compact electronic box for data
preprocessing/transmission, and a smartphone/tablet that sends signals over the network to a remote
diagnostic center and receives their results. The functional diagram of the whole system is shown in
Figure 1.
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2.3. The Electronic Box
ECG signal conditioning, A/D conversion, nd wirel ss transmission to th smartph ne sing a
Bluetooth (BT) link are all carried out by means of an electr nic box connecte to the bodysuit through
standard ECG cables, as shown in Figure 4. The box was specifically designed and realized through a
3D printer, in order to contain the two small boards devoted, respectively, to analog and digital circuits.
The analog circuit for signal pre-processing operates a bandpass filter in the frequency range of
0.05–128 Hz with a controllable gain. Signal amplification was mandatory in order to exploit the full
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dynamic range of the Analog to Digital Converter (ADC) (i.e., 0–3.3 V), since the mother QRS peak has
a range of 100 uV–1 mV, and the fetal QRS peak recorded on the abdomen has an amplitude of only
1–100 uV. Thus, the circuit was designed with a gain of approximately 2000, in order to avoid ADC
saturation in case of baseline wander due to artifacts.
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The FECG recorded on the abdomen has a bandwidth in the range 0.05–100 Hz, which is
compatible with a sampling rate at 256 Hz imposed by constraints of the BT transmission link. In fact,
the 8 channels are all sent in real time to the device, since no high-level processing takes place on the
hardware device, and further increasing the sampling frequency might have caused data loss problems
due to the saturation of the BT link. Data are digitally converted by a 16 bit ADC. We decided to use
a 16 bit ADC because of the very low amplitude of abdominal ECG recordings. A 12 bit ADC was
actually tested in an earlier prototype, but it did not provide the required signal resolution.
The first experiments were accomplished using pre-existing boards dedicated to the acquisition
of electro-encephalography signals. Each of those boards supported two differential leads and was
based on the chips INA118U, which includes an instrumentation amplifier, and TLC274, which has 4
operational amplifiers. Both chips are produced by Texas Instruments. The original circuit layout was
not modified, but the passive components (i.e., resistors and capacitors) were changed to achieve the
required bandpass range (i.e., 0.05–128 Hz) and an amplification gain of 2000.
In order to reduce the power consumption and the overall circuit dimension, a new board was
designed from scratch and built based on the chips INA333 and OPA2333 also from Texas Instruments,
which have much lower current profiles. Moreover, a significant difference with the preliminary board
consisted in introducing a driven-leg circuit into the new one. This circuit takes the signal from the
inputs, sums and negatively amplifies it, and finally reintroduces the result into the patient leg with
the aim of improving the performance in terms of noise rejection and signal quality. This allows a
significant reduction of the alternating current interference.
A different board was used to digitally sample the signal and send the data stream through
a BT link to the external device. This board may receive up to 8 analog inputs from the analog
preprocessing boards, and a 16 bit ADC with 50 µV voltage resolution samples each channel at
256 Hz. The microprocessor ARM TR711FR2 manufactured by STMicroelectronics oversees the entire
functioning of the circuit. The board is powered by a 3.6 V Li-Ion rechargeable battery, similar to those
used for powering mobile phones, which is also used to power up the preprocessing analog boards
and guarantees up to 6 h of life.
A button controls switching on and off the entire device, and a LED is provided, which shines red
when the device is powered-on and turns green during data transmission.
A further improvement of the electronics has recently been introduced by Torti et al. [20],
extracting FECG on a FPGA device, which enormously decreases the amount of data transmitted via
the BT connection, as explained in the next section of the paper. Unfortunately, this new approach
requires a complete redesign of the electronics, and it will be included in the next release of the system.
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2.4. FECG Extraction
In Abdominal FECG (AECG) recordings, the information source is FECG even though Maternal
ECG (MECG) and a broad spectrum of different noises (AC interference, movement artifacts, baseline
wander, electrode contact) are superimposed on it. Among disturbing noise sources, the most
significant is MECG. Fetal QRS (FQRS) might be up to 10 times smaller than Maternal QRS (MQRS),
thus with a very low SNR. This implies that P and T fetal ECG waves could not be reliably detected,
and the only event from FECG that could be extracted after serious pre-processing is the FQRS. In
addition, the classical information used in antenatal monitoring consists of FHR time series, built by
identifying R-R intervals in FECG (or an equivalent as in the case of CTG).
However, in our case, FECG might not be present in some of the 8 ECG leads, depending on the
position of the fetus in uterus. Thus, the FECG extraction algorithm should be able to detect when
FQRS detection is successful and, in those cases, to recognize which one of the 8 ECG leads sources
is the best FECG. Both noise removal and selection of the best FECG channel are extremely complex
tasks to accomplish.
The extraction of Fetal ECG in the current system is performed off-line. It is organized in different
steps to satisfy the following specifications: it must be (i) automatic, (ii) easy to be implemented, and
(iii) working with a limited number of ECG leads (8 in our system).
Literature proposes a vast number of algorithms for Fetal and Maternal QRS identification, MECG
suppression, and FECG extraction. The two main families of algorithms for FECG extraction are
(i) methods based on Blind Source Separation and Independent Component Analysis [21] and (ii)
methods removing maternal QRS after an averaging and subtracting procedure [22,23]. Although
we explored both solutions, a method belonging to the second family is implemented in the actual
release of the system. The algorithm consists of a modified and upgraded version of the Martens
algorithm [24,25].
Before the algorithm application, it is necessary to submit Abdominal ECG (AECG) signals to
five-step preprocessing:
(a). AECG recordings submitted to a 50 Hz digital FIR notch filter.
It removes 50 Hz power-line interference, in a very sharp and selective way. Surrounding
frequency components are preserved (better than a notch analog filter).
(b). Baseline wander and high frequency noise removal from the output signal at step 1 through a
FIR pass-band filter (3 to 80 Hz).
(c). Resampling of all 8 signals at 1000 Hz (T = 1 ms) in order to obtain the X50FILj signals (j = 1 . . . 8)
(d). X50FILj signals submitted to a low-pass filter, moving-average, order 30 (like a moving window
of 30 ms, with cutoff frequency 15 Hz), and results stored as XMAj signals.
(e). Computation of the difference between X50FILj and XMAj: Yj = X50FILj − XMAj.
Yj signals significantly enhance the high frequency components belonging to both fetal and
maternal QRSs.
2.4.1. Detection of MECG
The algorithm starts with the localization of Maternal QRSs (adapted from [24]).
QRS enhancement is based on Principal Component Analysis (PCA). The input is Γ, a [8xN] data matrix
containing the eight Yj signals, each of the N samples, and the output is the first principal component C,
representing the linear combination that yields maximum variance. Inter-signal correlation will be
large for ECG related components, as it will be small in case of noise. Since FECG is not always present
in the 8 channels, the signal C almost suppresses the FECG component.
C is divided into windows of 1 s, in order to be sure that at least a maternal QRS is contained in
each window, and the absolute max (AMax) is computed in each window and temporally located.
At this point, by taking a 100 ms window centered in AMax as single temporary MQRS template,
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the crosscorrelation between this MQRS template and the 1 s window is computed. The peak of
crosscorrelation identifies the beginning of MQRS. MQRS peak is detected and located by finding the
maximum within the next 100 ms after the crosscorrelation peak. Thus, by considering all windows,
we obtain an array t(k) containing the time locations of MQRSs.
The algorithm then goes back to the Yj signals to extract the running MQRS template in each
channel (TempMQRSj).
2.4.2. Construction of MQRS Template
For each Yj signal, a window of 100 ms centered in each t(k) is set (WMQRSj(k)). A running
template TempMQRSj(k) is then obtained by averaging ten WMQRSj(k) windows preceding the actual k
in the Yj signal. The current MQRS is removed by subtracting, from the Yj signal, the TempMQRSj(k)
template, scaled by a value aj(k), which minimizes mean square difference between the current QRS
and the template.
aj(k) = a, in which a→ min‖WMQRSj(k)− a·TempMQRSj(k)‖2
After averaging and MQRS template subtraction, we obtain 8 possible FECG signals:
Fj(i) = Yj(i)− [aj(k)·TempMQRSj(k)](i)
2.4.3. Extraction of FHR Series
The extraction of FQRS from the Fjs follows the same procedure applied for MQRS, except the
enhancement based on PCA method, because fetal ECG is often visible in a small number (2 or 3)
of abdominal leads only. Thus, no information is available about the presence of FQRSs in all 8 Fjs.
For this reason, FQRS detection is accomplished in all channels, despite what has been described
for MQRS.
Detection of FQRS complexes on the Fjs is obtained by dividing each Fj in consecutive windows
of 0.5 s, finding the absolute peak in each window and considering 60 ms around it as a temporary
FQRS template. The crosscorrelation between this FQRS template and the 0.5 s window is computed.
As for MQRS, the crosscorrelation peak identifies the beginning of FQRS. FQRS peak is detected and
located by finding the maximum within the next 60 ms after the crosscorrelation peak.
This procedure gives 8 arrays tfj(k) containing the time locations of detected FQRSs (equivalent to
R-R series). Fetal R-R interval extraction is unreliable, or fetal ECG is not detectable, when inter beat
distance shows values that are far from expected and/or noisy.
In order to determine if one or more tfj(k)s is reliable, we compute a Quality parameter, as
explained in the next paragraph. Figure 5 shows a chunk of a Yj signal (j = 3) with the detection of
both MQRS and FQRS.
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2.4.4. Quality Parameter
The quality parameter [17] ranks fetal QRS detection according to the reliability level of the inter
beat distance.
RRj(i) = t f j(i + 1)− t f j(i)
The 8 Fetal RR series are ordered on the basis of the qj index from the lowest to the highest. Low
qj values indicate good performances and allow selecting the lead (over the available 8’s) with the best
detection performance and the best fetal inter beat distance.





‖RRj(i + 1)− RRj(i)‖)
The computation of the qj parameter, ranking the quality of extracted FECG and FHR, ends the
algorithm application.
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2.4.5. FECG Extraction through Field Programmable Gate Array (FPGA)
As reported in the previous subsection, an alternative technological approach to FECG extraction
has been already designed and tested in our laboratory. The solution implemented by Torti et al. [20]
explores the development of a special purpose custom computational unit performing fetal signal
extraction to achieve lower power consumption and faster processing times in view of a potential final
Application Specific Integrated Circuit (ASIC) implementation.
In this case the FPGA-based FECG extraction unit exploits a well-known blind source separation
technique called Infomax [26]. It is one of the best methods in terms of reliability and documentation
for implementing FECG extraction on a dedicated hardware circuit. The work in [20] describes
the corresponding algorithm implementation; it produces eight different signals, which should be
classified in order to correctly point out the channels related to mother (maternal signal), to fetus
signal, or to noise. In addition, the classification is automatically performed and relies on a series of
filter banks capable of highlighting the QRS complex, followed by different K-means instances. The
architecture has been designed and implemented on an Altera Stratix V device. It is a high-end FPGA
that provides the necessary hardware resources featuring relatively low power consumption. This
architecture has been tested on a database made up of 343 real tracks. The results reported in [20]
show that the developed architecture is real time compliant with a power consumption of about 0.5
W. In terms of elaboration speed, the proposed implementation outperforms the other solutions in
the literature based on PIC, DSP and FPGA. In particular, the proposed architecture elaborates 4 s of
recording in less than 30 ms. Moreover, the FPGA resource consumption of this architecture is low;
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therefore, it is possible to implement other functionalities, such as data encryption for the separated
tracks. On the other hand, it is also possible to lower the power consumption by adopting a less
performant device, such as an Altera Cyclone V device.
This new solution implies a re-design of the electronics of the whole system, and it will be included
in the next release of our system.
2.5. The Remote Monitoring Service
A fundamental element for an architecture delivering remote monitoring services is represented
by the mobile device, which acts as a networking endpoint for the hardware device capturing signals.
In fact, the combination of those two devices implements a remote station that may be deployed
anywhere, including the patient’s domicile. That station is able to capture physiological signals and
send them in real time to the hospital center where they may be perused by the staff. For our project,
we decided to use a commercial smartphone as the mobile device due to its low cost compared to its
high-end computational capability. Moreover, the patient is expected to already own a smartphone
and be comfortable with it, further reducing the economic impact of the intervention. Finally, through
the use of the smartphone the patient may acquire and send data virtually anytime and anywhere,
with no additional requirement other than the availability of network coverage by the phone carrier to
which she is already subscribed. The smartphone operates according to a store and forward paradigm,
so that, whenever any problem is experienced with the carrier, unsent data are never lost. Instead,
they will be cached in the internal smartphone memory waiting to be transparently transmitted as
soon as the network connectivity is recovered. To implement the mobile app, we chose the AndroidTM
platform because of its widespread availability on a large number of different devices with various
capabilities. Furthermore, the open source approach adopted by AndroidTM makes available a large
knowledge body about its internals that is shared among enthusiast developers.
In Figure 7, we portray the architecture of the mobile app, which is modeled after a multi agent
paradigm [27] and was devised based on our experience in developing similar projects [28,29]. The
modularity of that framework supports the rapid prototyping of telemedicine services through the
reuse of its components, thereby simplifying the switch to different medical contexts.
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As it transpires from the figure, the whole architecture is centered on Data Types, which is the
core component supporting the store and forward paradigm. Data are saved either exploiting the
Sqlite3 database or as plain text files. In our case, data representing patient information, such as
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demographic data, as well as any note written by the patient herself and concerning the specific details
of the acquisition to be shared with the clinic staff, are stored exploiting the Sqlite3 relational structure.
Sampled values are stored instead, exploiting the file paradigm that is more efficient for long time
series. Data Types interacts then with the Synchronization module that implements the two-way data
link with the clinic server.
The Synchronization module exchanges data with the clinic server implementing the retry and
error recovery policy. This component has been successfully exploited and validated in different areas
of remote monitoring involving home patients [30,31]. Two additional modules in the architecture are
represented by the Manual Input and Automatic Input. The former allows the use of the touch-screen
for manually entering data, while the latter exploits BT for connecting with an external device. Finally,
a set of Plugins are used to customize the behaviour according to a specific domain, prompting the
user for input or providing specialized views over data for the chosen application (i.e., Patient Diary or
Local Views). In our case, those implement the remote control for the hardware capturing device and
display data to the user as shown in Figure 8, which includes a plain ECG signal.
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At the clinic site, a server is located acting as a backend and including a synchronization engine
that collects all the signal traces sent by the various patients through their apps. The server also
implements the logic for extracting the FHR from the combined signals acquired and an interface for
their perusal. Its operation is modeled as follows. It stores into the patient’s Personal Health Record
(PHR) the incoming 8 tracks that are sent after a successful recording stamped with the date-time
of their acquisition. Any recording then undergoes a processing pipeline composed of three stages.
The first stage includes a filter suppressing the noise superimposed to the recording, as well as the
mother ECG signal, in order to emphasize the fetal component. The second pipeline stage selects the
most interesting track out of the 8 available ones on which FHR will be measured, while the third one
eventually accomplishes the actual FHR measurement.
The server functionality is exposed through a web application that is accessed by the doctors
overseeing the service. That app includes the usual facilities for selecting patients and navigating
across the sessions recorded for each one of them. Once a session is selected, the application displays
the 8 tracks, as well as the computed FHR for visual inspection. All tracks may also be exported for
further analysis using specialized software tools.
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3. Results
The new prototype was tested on five voluntary pregnant women at the 37th week of gestation
during everyday life conditions. They all gave us the informed consent for this testing phase.
3.1. Garment
All subjects reported easiness of wearing the elastic bodysuit and great comfort during the
recording sessions. The abdominal ECG was recorded while subjects were sitting on a chair and
reading a book. We collected more than 10 h of abdominal ECG in different sessions. The average
duration of each tracing was 30 min ± 4 min.
All women had a normal course of pregnancy, and we verified “a posteriori” that they had a
physiological delivery and the newborns were healthy.
In order to prepare for signal acquisition, it was only required that the subject connected the leads
coming out of the sensorized garment to the electronic box, which is dedicated to analog preprocessing,
analog-to-digital conversion, and digital processing. She should also turn on the smartphone, activate
the Telefetalcare app installed on it, and check that the two components were successfully paired and
data transmission over the BT wireless link started.
3.2. Electronics
An essential prerequisite of our solution was the reduction of any cost related to its deployment
and management. To achieve this goal, we decided to devoid the electronic box acting as the
signal-capturing device of any display, on the basis that smartphones already have screens smart
enough to serve for that purpose. Furthermore, mobile devices make also available the primitives
for easily programming their windowing system to achieve an effective user interaction through
simple touch gestures. Thus, the mobile device besides offering the possibility of remotely sending
the acquired signals is also used as the control unit of the hardware device. The use of BT technology
allows pairing the hardware device with a wide range of receivers. Besides mobile devices, also
laptops, hubs, or docking stations could be able to pair with it inasmuch they are endowed with a
suitable application.
Once the mobile terminal was successfully connected through the BT link to the hardware device,
the patient started the acquisition and observed in real time on its screen the signals being acquired.
This feature is particularly useful, since it gives immediate feedback to the patient about the proper
operation of the system. Thus, if a patient experiences any problem with one of the channels, possibly
due to a lead that is not properly connected and has become noisy, the acquisition may be stopped, the
lead may be repositioned, and the acquisition may be started again.
3.3. Transmission
We opted for a deferred transmission, in which the mobile terminal acts according to a
store-and-forward paradigm saving a track of variable length growing at a rate of nearly 256 kBytes
for every minute of sampling. When, according to the directions given by the health care staff, the
expected length was achieved (usually 30 min), the patient could stop the acquisition and select
whether to send that acquisition to the center, keep it locally, or discard it altogether.
3.4. Signal Quality
The quality of the electrocardiographic recordings was then compared to other commercial
devices, showing good results and flat band response in the frequency range 0.1–100 Hz, as reported
in [11]. During the tests, data coming from the abdominal ECG leads of the wearable garment were
preprocessed and transmitted to a laptop through BT connection. A graphical user interface was
developed to display signals in real time; also, on the laptop that was used to test the algorithms for the
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extraction of FECG from abdominal recordings, the fetal QRS and the signal classification according to
the quality index were identified.
3.5. Performance of Classifiers
The performance of the actual FECG extraction algorithm was evaluated on real data acquired
using Telefetalcare, achieving reliable results.
For each recording, accuracy (AC) and sensitivity (SE) of fetal and maternal QRS detection were
quantified. An expert clinician evaluated the 1st-ranked traces with q value < 0.1s (according to the
defined quality parameter) by counting the number of (i) QRS correctly detected (TP), (ii) missed QRS
(FN), and (iii) QRS wrongly detected (FP).
AC and SE were computed in the following way:
AC =
TP




Classification accuracy = correct predictions/total predictions × 100.
For maternal QRS detection, we obtained an overall accuracy AC = 98.52% and sensitivity SE = 99.5%.
For fetal QRS detection, overall AC = 91.26% and SE = 92.94%.
The FHR time series were then analyzed at the medical center (University of Naples Federico II)
using the software we developed (2CTG2) and the most recent algorithms for the multiparametric
analysis [32] and classification [18]. All subjects showed parameters belonging to the normal ranges,
as we selected healthy pregnant women.
In this testing phase, we did not ask pregnant women who were at risk or had known fetal
pathology to participate. For this reason, we do not report results on the classification of fetal conditions.
The large amount of data obtained from the application of classification parameters to Fetal Heart Rate
data from CTG recordings confirmed their ability in the fetal state classification [33]. These results
were used to design the processing architecture.
The next step of our project will be to use the system in collaboration with the Obstetrics Clinic
and to record tracings from a large population of pregnant women, comprising subjects at risk or with
a known fetal pathology, in order to check the classifying algorithms and to generate warnings and
alarms through our mobile application.
4. Discussion
In the past decade, there have been many attempts to exploit wearable monitoring systems to
provide better care for patients. As a result, no convincing evidence emerged that these systems provide
a cost effective solution to the problem of promptly detecting any situation that requires medical
action [34]. As suggested in [35], the main reason for that is not due to intrinsic technical failures or
limitations but to the underestimation of the organizational issues involved for their adoption. This
becomes a sensible topic, since the majority of remote monitoring efforts have been addressing the
treatment of patients affected by chronic diseases with the aim of promptly detecting any symptom
calling for an action in order to avoid or decrease the onset of complications.
While there is a great potential for remote monitoring in this area [36], the long term perspective
of chronic diseases, mainly involving elderly patients, poses a higher burden on the organization
side. With respect to this, there is a lack of guidelines for the implementation of long term home
tele-health solutions, as well as no consensus on specific clinical indicators universally trusted by
clinicians drawing on data that may be automatically acquired or directly provided by patients. Those
aspects, combined with the failure to account for a broader evaluation context also encompassing
legal, ethical, organizational, and practical aspects, are delaying the mainstream adoption of home
monitoring system for chronic patients [37].
In this context pregnancy, although it does not represent a chronic disease, can be considered like
a time-bounded chronic risky condition, and home-monitoring pregnant women involves the same
Technologies 2018, 6, 44 14 of 16
organizational problems as monitoring chronic patients. However, if remote monitoring is conceived
of as a whole “service” comprising wearable devices for collecting signals, electronics for transmitting
data, and suitable software and algorithms for analyzing data supporting the clinician specialist to take
decisions on the basis of the analyzed data, the likelihood of achieving a successful “tele-monitoring”
system increases enormously.
The paper describes the design and development of an end-to-end system for monitoring FHR
during pregnancy. The whole system relies on a wearable sensorized garment for acquiring abdominal
FECG recordings, a telemedicine module to send data to a clinic center, and a clinic server equipped
with software applications able to perform an advanced quantitative analysis of the FHR variability
signal through non-linear and soft computing algorithms to obtain the best classification of the fetal
condition. The remote wearable device can be used by pregnant women at home without the need for
external support by clinicians.
On the technical side, a recent work by Jezewski et al. [38] demonstrated the equivalence of
abdominal FECG and Doppler Ultrasound (CTG) methods, in terms of ability of clinical parameters to
distinguish between normal and pathological fetuses. This fact supports the remote use of advanced
signal processing methods already developed for CTG analysis antepartum in the clinical center
deputed to the tele-monitoring service [13]. Moreover, a recent review paper on telemonitoring in
obstetrics [39] shows “the added value, for both mother and child, of telemonitoring used in prenatal
follow-up program” and suggests that it can be recommended for pregnant women at risk.
Our system, within a limited set of pregnant women, demonstrated both accuracy in measuring
and extracting FHR and comfort for the patients, who can check the fetal condition while staying at
home by means of a low cost wearable device and a reliable telemedicine service.
Author Contributions: All authors equally contributed to this paper. In particular: Conceptualization,
M.G. Signorini and G. Magenes; Methodology, M.G. Signorini, G. Lanzola, A. Fanelli, E. Torti and G. Magenes;
Hardware, A. Fanelli, G. Magenes; Software, G. Lanzola, A. Fanelli and E. Torti.; Validation, M.G. Signorini,
G. Magenes, A. Fanelli.; Formal Analysis, A. Fanelli, M.G. Signorini; Investigation, G. Magenes; Resources,
M.G. Signorini and G. Magenes.; Data Curation, A. Fanelli.; Writing-Original Draft Preparation, G. Magenes,
M.G. Signorini, G. Lanzola, E. Torti; Writing-Review & Editing, G. Magenes, G. Lanzola, M.G. Signorini;
Visualization, G. Magenes, G. Lanzola.; Supervision, G. Magenes.; Project Administration, M.G. Signorini.;
Funding Acquisition, M.G. Signorini and G. Magenes.
Funding: This research was funded by Italian PRIN National Project prot. N. 2008TERW82 Ministry of Education
and Research.
Acknowledgments: The authors are grateful to Dr. Marta Campanile, Ob-Gyn Clinics, University of Naples, for
the possibility of recording patients in her laboratory.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Norris, A. Essentials of Telemedicine and Telecare; John Wiley & Sons: Hoboken, NJ, USA, 2001.
2. Losiouk, E.; Lanzola, G.; Del Favero, S.; Boscari, F.; Messori, M.; Rabbone, I.; Bonfanti, R.; Sabbion, A.;
Iafusco, D.; Schiaffini, R.; et al. Parental evaluation of a telemonitoring service for children with Type 1
Diabetes. J. Telemed. Telecare 2017. [CrossRef] [PubMed]
3. Gaikwad, R.; Warren, J. The role of home-based information and communications technology interventions
in chronic disease management: A systematic literature review. Health Inform. J. 2009, 15, 122–146. [CrossRef]
[PubMed]
4. Martirosyan, M.; Caliskan, K.; Theuns, D.A.M.J.; Szili-Torok, T. Remote monitoring of heart failure: Benefits
for therapeutic decision making. Expert Rev. Cardiovasc. Ther. 2017, 15, 503–515. [CrossRef] [PubMed]
5. Farnia, T.; Jaulent, M.C.; Steichen, O. Evaluation Criteria of Noninvasive Telemonitoring for Patients with
Heart Failure: Systematic Review. J. Med. Internet Res. 2018, 20, e16. [CrossRef] [PubMed]
6. Schoenfeld, M.H.; Compton, S.J.; Mead, R.H.; Weiss, D.N.; Sherfesee, L.; Englund, J.; Mongeon, L.R. Remote
monitoring of implantable cardioverter defibrillators: A prospective analysis. Pacing Clin. Electrophysiol.
2004, 27 Pt 1, 757–763. [CrossRef] [PubMed]
Technologies 2018, 6, 44 15 of 16
7. Varma, N.; Michalski, J.; Epstein, A.E.; Schweikert, R. Automatic remote monitoring of implantable
cardioverter-defibrillator lead and generator performance. Circ. Arrythmia Electrophysiol. 2010, 3, 428–436.
[CrossRef] [PubMed]
8. Lanzola, G.; Scarpellini, S.; Di Palma, F.; Toffanin, C.; Del Favero, S.; Magni, L.; Bellazzi, R. Monitoring
Artificial Pancreas Trials through Agent-based Technologies. J. Diabetes Sci. Technol. 2014, 8, 216–224.
[CrossRef] [PubMed]
9. Di Rienzo, M.; Meriggi, P.; Rizzo, F.; Castiglioni, P.; Lombardi, C.; Ferratini, M.; Parati, G. Textile technology
for the vital signs monitoring in telemedicine and extreme environments. IEEE Trans. Inf. Technol. Biomed.
2010, 14, 711–717. [CrossRef] [PubMed]
10. Curone, D.; Secco, E.L.; Tognetti, A.; Loriga, G.; Dudnik, G.; Risatti, M.; Whyte, R.; Bonfiglio, A.; Magenes, G.
Smart garments for emergency operators: The proetex project. IEEE Trans. Inf. Technol. Biomed. 2010, 14,
694–701. [CrossRef] [PubMed]
11. Vainoras, A.; Marozas, V.; Korsakas, S.; Gargasas, L.; Siupsinskas, L.; Miskinis, V. Cardiological
telemonitoring in rehabilitation and sports medicine. Stud. Health Technol. Inform. 2004, 105, 121–130.
[PubMed]
12. Giansanti, D.; Maccioni, G.; Macellari, V.; Mattei, E.; Triventi, M.; Censi, F.; Calcagnini, G.; Bartolini, P.
A novel, user-friendly step counter for home telemonitoring of physical activity. J. Telemed. Telecare 2008, 14,
345–348. [CrossRef] [PubMed]
13. Di Lieto, A.; De Falco, M.; Campanile, M.; Papa, R.; Torok, M.; Scaramellino, M.; Pontillo, M.; Pollio, F.;
Spanik, G.; Schiraldi, P.; et al. Four years’ experience with antepartum cardiotocography, using telemedicine.
J. Telemed. Telecare 2006, 12, 228–233. [CrossRef] [PubMed]
14. Buysse, H.; De Moor, G.; Van Maele, G.; Baert, E.; Thienpont, G.; Temmerman, M. Cost-effectiveness of
telemonitoring for high-risk pregnant women. Int. J. Med. Inform. 2008, 77, 470–476. [CrossRef] [PubMed]
15. Tagliaferri, S.; Fanelli, A.; Esposito, G.; Esposito, F.G.; Magenes, G.; Signorini, M.G.; Campanile, M.;
Martinelli, P. Evaluation of the Acceleration and Deceleration Phase-Rectified Slope to Detect and Improve
IUGR Clinical Management. Comput. Math. Methods Med. 2015. [CrossRef] [PubMed]
16. Hoyer, D.; Z˙ebrowski, J.; Cysarz, D.; Gonçalves, H.; Pytlik, A.; Amorim-Costa, C.; Bernardes, J.;
Ayres-de-Campos, D.; Witte, O.W.; Schleußner, E.; et al. Monitoring fetal maturation-objectives, techniques
and indices of autonomic function. Physiol. Meas. 2017, 38, R61–R88. [CrossRef] [PubMed]
17. Fanelli, A.; Signorini, M.G.; Ferrario, M.; Perego, P.; Piccini, L.; Andreoni, G.; Magenes, G. Telefetalcare:
A first prototype of a wearable fetal electrocardiograph. In Proceedings of the IEEE Engineering in Medicine
and Biology Society Conference, EMBC 2011, Boston, MA, USA, 30 August–3 September 2011; pp. 6899–6902.
18. Magenes, G.; Bellazzi, R.; Malovini, A.; Signorini, M.G. Comparison of data mining techniques applied to
fetal heart rate parameters for the early identification of IUGR fetuses. In Proceedings of the IEEE Engineering
in Medicine and Biology Society EMBC 2016, Orlando, FL, USA, 16–20 August 2016; pp. 916–919. [CrossRef]
19. Giuliano, N.; Annunziata, M.L.; Esposito, F.G.; Tagliaferri, S.; Di Lieto, A.; Magenes, G.; Signorini, M.G.;
Campanile, M.; Arduini, D. Computerised analysis of antepartum foetal heart parameters: New reference
ranges. J. Obstet. Gynaecol. 2017, 37, 296–304. [CrossRef] [PubMed]
20. Torti, E.; Koliopoulos, D.; Matraxia, M.; Danese, G.; Leporati, F. Custom FPGA processing for real-time fetal
ECG extraction and identification. Comput. Biol. Med. 2017, 80, 30–38. [CrossRef] [PubMed]
21. Zarzoso, V.; Nandi, A.K. Noninvasive fetal electrocardiogram extraction: Blind separation versus adaptive
noise cancellation. IEEE Trans. Biomed. Eng. 2001, 48, 12–18. [CrossRef] [PubMed]
22. Cerutti, S.; Baselli, G.; Civardi, S.; Ferrazzi, E.; Marconi, A.M.; Pagani, M.; Pardi, G. Variability analysis of
fetal heart rate signals as obtained from abdominal electrocardiographic recordings. J. Perinat. Med. 1986, 14,
445–452. [CrossRef] [PubMed]
23. De Lathauwer, L.; De Moor, B.; Vandewalle, J. Fetal electrocardiogram extraction by blind source subspace
separation. IEEE Trans. Biomed. Eng. 2000, 47, 567–572. [CrossRef] [PubMed]
24. Martens, S.M.M.; Mischi, M.; Oei, S.G.; Bergmans, J.W.M. An Improved Adaptive Power Line Interference
Canceller for Electrocardiography. IEEE Trans. Biomed. Eng. 2006, 53, 2220–2231. [CrossRef] [PubMed]
25. Martens, S.M.; Rabotti, C.; Mischi, M.; Sluijter, R.J. A robust fetal ECG detection method for abdominal
recordings. Physiol. Meas. 2007, 28, 373–388. [CrossRef] [PubMed]
26. Bell, J.; Sejnowski, T.J. An information maximization approach to blind separation and blind deconvolution.
Neural Comput. 1995, 7, 1129–1159. [CrossRef] [PubMed]
Technologies 2018, 6, 44 16 of 16
27. Capozzi, D.; Lanzola, G. An agent-based architecture for home care monitoring and education of chronic
patients. In Proceedings of the IEEE Conference Complexity in Engineering, COMPENG’10, Rome, Italy,
22–24 February 2010; pp. 138–140. [CrossRef]
28. Lanzola, G.; Capozzi, D.; D’Annunzio, G.; Ferrari, P.; Bellazzi, R.; Larizza, C. Going mobile with a multiaccess
service for the management of diabetic patients. J. Diabetes Sci. Technol. 2007, 1, 730–737. [CrossRef] [PubMed]
29. Lanzola, G.; Ginardi, M.G.; Mazzanti, A.; Quaglini, S. Gquest: Modeling patient questionnaires and
administering them through a mobile platform application. Comput. Methods Programs Biomed. 2014,
117, 277–291. [CrossRef] [PubMed]
30. Losiouk, E.; Lanzola, G.; Galderisi, A.; Trevisanuto, D.; Steil, G.M.; Facchinetti, A.; Cobelli, C.
A telemonitoring service supporting preterm newborns care in a neonatal intensive care unit. In Proceedings
of the 3rd IEEE International Forum on Research and Technologies for Society and Industry (RTSI) 2017,
Modena, Italy, 11–13 September 2017. [CrossRef]
31. Capozzi, D.; Lanzola, G. A generic telemedicine infrastructure for monitoring an artificial pancreas trial.
Comput. Methods Programs Biomed. 2013, 110, 343–353. [CrossRef] [PubMed]
32. Fanelli, A.; Magenes, G.; Campanile, M.; Signorini, M.G. Quantitative assessment of fetal well-being through
CTG recordings: A new parameter based on phase-rectified signal average. IEEE J. Biomed. Health Inform.
2013, 17, 959–966. [CrossRef] [PubMed]
33. Signorini, M.G.; Fanelli, A.; Magenes, G. Monitoring fetal heart rate during pregnancy: Contributions from
advanced signal processing and wearable technology. Comput. Math. Methods Med. 2014, 707581. [CrossRef]
[PubMed]
34. Whitten, P.S.; Mair, F.S.; Haycox, A.; May, C.R.; Williams, T.L.; Hellmich, S. Systematic review of cost
effectiveness studies of telemedicine interventions. Br. Med. J. 2002, 324, 1434–1437. [CrossRef]
35. Hardisty, A.R.; Peirce, S.C.; Preece, A.; Bolton, C.E.; Conley, E.C.; Gray, W.A.; Rana, O.F.; Yousef, Z.; Elwyn, G.
Bridging two translation gaps: A new informatics research agenda for telemonitoring of chronic disease.
Int. J. Med. Inform. 2011, 80, 734–744. [CrossRef] [PubMed]
36. Pare, G.; Jaana, M.; Sicotte, C. Systematic review of home telemonitoring for chronic diseases: The evidence
base. J. Am. Med. Inform. Assoc. 2007, 14, 269–277. [CrossRef] [PubMed]
37. Koch, S. Home telehealth current state and future trends. Int. J. Med. Inform. 2006, 75, 565–576. [CrossRef]
[PubMed]
38. Jezewski, J.; Wrobel, J.; Matonia, A.; Horoba, K.; Martinek, R.; Kupka, T.; Jezewski, M. Is Abdominal Fetal
Electrocardiography an Alternative to Doppler Ultrasound for FHR Variability Evaluation? Front. Physiol.
2017, 16, 305. [CrossRef] [PubMed]
39. Lanssens, D.; Vandenberk, T.; Thijs, I.M.; Grieten, L.; Gyselaers, W. Effectiveness of Telemonitoring in
Obstetrics: Scoping Review. J. Med. Internet Res. 2017, 19, e327. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
